Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(75.0%)
Phase 2
1(25.0%)
4Total
Phase 3(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00659347Phase 2Terminated

Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

Role: lead

NCT00281645Phase 3Completed

Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain

Role: lead

NCT00295724Phase 3Completed

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

Role: lead

NCT00295711Phase 3Completed

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

Role: lead

All 4 trials loaded